Tag: covid-19

Glaxo Smith Kline LLC Awarded $651M for Sotrovimab Therapeutic for the treatment of COVID-19

Posted on by Eric Coffie

Glaxo Smith Kline LLC, Durham, North Carolina, was awarded a $651,094,500 firm-fixed-price contract for Sotrovimab Therapeutic for the treatment of COVID-19. Bids were solicited via the internet with one received. Work will be performed in Durham, North Carolina, with an estimated completion date of March 31, 2022. Fiscal 2010 Defense Production Act funds in the amount of $651,094,500 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity (W58P05-22-C-0002). (Awarded Nov. 15, 2021)

GlaxoSmithKline (GSK) gives anxiety, asthma, and other ailments the ax. One of the top five pharmaceutical firms in the world, GSK’s bestsellers include respiratory, neurological, cardiovascular and dermatology drugs, as well as vaccines and antivirals and consumer healthcare products. It boasts four billion-dollar drugs: Advair/Seretide, its stalwart asthma medication; Relvar/Breo Ellipta, a chronic obstructive pulmonary disease treatment; and two HIV medications, Triumeq and Tivicay. In the consumer healthcare business, GSK racks up big sales from its Sensodyne toothpaste brand, joint-pain relief medicine Voltaren, and fever relief medicine Panadol. Based in the UK, GSK has customers across the globe. (www.dnb.com)

OraSure Technologies Inc. Awarded $109M for the increased domestic manufacturing capability of rapid antigen self-tests for home care testing

Posted on by Eric Coffie

OraSure Technologies Inc., Bethlehem, Pennsylvania, was awarded a $109,000,000 firm-fixed-price contract for the increased domestic manufacturing capability of rapid antigen self-tests for home care testing. This contract provides for the retrofit of a production facility and a new additional facility with machinery to increase domestic COVID-19 rapid test production capacity. Work will be performed in Bethlehem, Pennsylvania, and is expected to be completed by March 31, 2024. This award is the result of a COVID-19 Joint Acquisition Task Force Commercial Solution Opening. Fiscal 2021 American Rescue Plan Act, Department of Health and Human Services other funds in the amount of $109,000,000 are being obligated at the time of the award. There are known congressional interest in this action. Air Force Life Cycle Management Center, Hanscom Air Force Base, Massachusetts, is the contracting activity (FA8730-21-S-C001). (Awarded Sept. 30, 2021)

When it comes to diagnostic tests, OraSure is certain it can deliver results. The oral specimen kits and other diagnostic tests developed by OraSure Technologies are designed to detect drug use and certain infectious diseases, namely HIV and hepatitis C. Its OraSure products use oral specimens rather than traditional blood or urine-based methods to test for HIV. The Intercept line uses oral samples to test for marijuana, cocaine, opiates, PCP, and amphetamines. OraSure has also developed a rapid HIV blood diagnostic testing method, and it has entered the genetic testing market through its DNAG subsidiary. OraSure sells its products in the US (largest single market) and internationally to health care facilities and medical laboratories.   (www.dnb.com)

Astrazeneca Pharmaceuticals LP Awarded $286.9M Contract For 200 million Doses of AZD1222 Vaccine for COVID- 19.

Posted on by Eric Coffie

AstraZeneca Pharmaceuticals LP, Wilmington, Delaware, was awarded a $286,927,159 firm-fixed-price contract for the delivery of 200 million doses of AZD1222 vaccine for COVID- 19. Bids were solicited via the internet with one received. Work will be performed in West Chester Township, Ohio; and Albuquerque, New Mexico, with an estimated completion date of June 30, 2021. Fiscal 2021 other procurement (Army) funds in the amount of $286,927,159 were obligated at the time of the award. U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity (W15QKN-21-C-0003). (Awarded Oct. 28, 2020).

AstraZeneca Pharmaceuticals LP manufactures, fabricates, and processes drugs in pharmaceutical preparations. The Company focuses on several therapeutic areas such as cardiovascular and metabolic, gastrointestinal, neuroscience, oncology, respiratory, and infection. AstraZeneca Pharmaceuticals operates globally. (www.bloomberg.com)

GlaxoSmithKline Awarded $342,000,000 Contract for COVID-19 Vaccines

Posted on by Eric Coffie

GlaxoSmithKline LLC, Research Triangle Park, North Carolina, was awarded a $342,000,000 firm-fixed-price contract to procure mass quantities of COVID-19 vaccines from multiple vendors to support military locations and personnel throughout the continental U.S. and outside the continental U.S.

Bids were solicited via the internet with one received. Work will be performed in Research Triangle Park, North Carolina, with an estimated completion date of Feb. 28, 2021. Fiscal 2020 research, development, test and evaluation (Army) funds in the amount of $342,000,000 were obligated at the time of the award. U.S. Army Contracting Command, Newark, New Jersey, is the contracting activity (W15QKN-20-C-0048).